awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52581473-10F30D52-C103-4972-BA96-C38B7AAC7CFB
Q52581473-10F30D52-C103-4972-BA96-C38B7AAC7CFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52581473-10F30D52-C103-4972-BA96-C38B7AAC7CFB
Cost-Effectiveness Analysis of Crohn's Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist.
P2860
Q52581473-10F30D52-C103-4972-BA96-C38B7AAC7CFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52581473-10F30D52-C103-4972-BA96-C38B7AAC7CFB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a478f78aa7ad9b992d134f7683fe61b116afaf8
P2860
Effectiveness and safety of vedolizumab for treatment of Crohn's disease: a systematic review and meta-analysis